These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27390524)

  • 1. The efficacy and safety of postoperative adjuvant transarterial embolization and radiotherapy in hepatocellular carcinoma patients with portal vein tumor thrombus.
    Bai T; Chen J; Xie ZB; Wu FX; Wang SD; Liu JJ; Li LQ
    Onco Targets Ther; 2016; 9():3841-8. PubMed ID: 27390524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
    Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
    Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of the treatment of transarterial chemoembolization combined with radiotherapy for hepatocellular carcinoma with portal vein tumor thrombus: A propensity score analysis.
    Li XL; Guo WX; Hong XD; Yang L; Wang K; Shi J; Li N; Wu MC; Cheng SQ
    Hepatol Res; 2016 Oct; 46(11):1088-1098. PubMed ID: 26783741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial chemoembolization plus immune checkpoint inhibitor as postoperative adjuvant therapy for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter cohort study.
    Yuan L; Feng J; Zhang Y; Lu C; Xu L; Liang C; Liu Z; Mao F; Xiang Y; Wang W; Wang K; Cheng S
    Eur J Surg Oncol; 2023 Jul; 49(7):1226-1233. PubMed ID: 36739252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
    Fan W; Yuan G; Fan H; Li F; Wu Y; Zhao Y; Yao W; Wang Y; Xue M; Yang J; Li J
    Clin Ther; 2019 Aug; 41(8):1463-1476. PubMed ID: 31303279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Transarterial Chemoembolization in Elderly Patients of Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Study.
    Tang Q; Huang W; Liang J; Xue J
    Front Oncol; 2021; 11():646410. PubMed ID: 34307128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis.
    Zhang XP; Wang K; Li N; Zhong CQ; Wei XB; Cheng YQ; Gao YZ; Wang H; Cheng SQ
    BMC Cancer; 2017 Dec; 17(1):902. PubMed ID: 29282010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy prior to or after transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a randomized controlled trial.
    Guo L; Wei X; Feng S; Zhai J; Guo W; Shi J; Lau WY; Meng Y; Cheng S
    Hepatol Int; 2022 Dec; 16(6):1368-1378. PubMed ID: 36271176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should transarterial chemoembolization be given before or after intensity-modulated radiotherapy to treat patients with hepatocellular carcinoma with portal vein tumor thrombus? a propensity score matching study.
    Li X; Guo W; Guo L; Lau WY; Ge N; Wang K; Cheng S
    Oncotarget; 2018 May; 9(36):24537-24547. PubMed ID: 29849959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: using a new classification.
    Niu ZJ; Ma YL; Kang P; Ou SQ; Meng ZB; Li ZK; Qi F; Zhao C
    Med Oncol; 2012 Dec; 29(4):2992-7. PubMed ID: 22200992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
    Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
    [No Abstract]   [Full Text] [Related]  

  • 13. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
    Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
    World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Tertiary Care Center Experience.
    Patidar Y; ; Mukund A; Sarin SK
    Indian J Radiol Imaging; 2021 Apr; 31(2):270-276. PubMed ID: 34556907
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical impact of combined transarterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: An external validation study.
    Yu JI; Park JW; Park HC; Yoon SM; Lim DH; Lee JH; Lee HC; Kim SW; Kim JH
    Radiother Oncol; 2016 Feb; 118(2):408-15. PubMed ID: 26830695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus.
    Peng ZW; Guo RP; Zhang YJ; Lin XJ; Chen MS; Lau WY
    Cancer; 2012 Oct; 118(19):4725-36. PubMed ID: 22359112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale, Multicenter, Propensity Mathching Score Analysis.
    Wang K; Guo WX; Chen MS; Mao YL; Sun BC; Shi J; Zhang YJ; Meng Y; Yang YF; Cong WM; Wu MC; Lau WY; Cheng SQ
    Medicine (Baltimore); 2016 Mar; 95(11):e3015. PubMed ID: 26986115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoembolization Plus Radiotherapy Versus Chemoembolization Plus Sorafenib for the Treatment of Hepatocellular Carcinoma Invading the Portal Vein: A Propensity Score Matching Analysis.
    Chu HH; Kim JH; Shim JH; Yoon SM; Kim PH; Alrashidi I
    Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32365655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Treated With Transarterial Chemoembolization and Sorafenib
    Hu HT; Luo JP; Cao GS; Li Z; Jiang M; Guo CY; Yuan H; Yao QJ; Geng X; Park JH; Cheng HT; Jiang L; Ma JL; Zhao Y; Li HL
    Front Oncol; 2021; 11():806907. PubMed ID: 35004330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study.
    Huang M; Lin Q; Wang H; Chen J; Bai M; Wang L; Zhu K; Jiang Z; Guan S; Li Z; Qian J; Li M; Pang P; Shan H
    Eur Radiol; 2016 Oct; 26(10):3428-36. PubMed ID: 26792430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.